1-5 of 5
Miguel Hernandez, MD
Close
Sort by
Journal Articles

Clinical Significance of Sensitive Flow-MRD Monitoring in Elderly Multiple Myeloma Patients on the Pethema/GEM2010MAS65 Trial

Bruno Paiva, PhD, Maria Angeles Montalbán, Noemi Puig, MD PhD, Lourdes Cordon, Joaquin Martinez-Lopez, Enrique M Ocio, MD PhD, Miguel Hernandez, MD, Ana Isabel Teruel, Mercedes Gironella, MD, Maria Asunción Echeveste, Laura Rosiñol, MD PhD, Rafael Martinez, MD, Albert Oriol, MD, Jesus Martin, MD, Cristina Encinas, Norma Carmen Gutierrez, PhD MD, María-Belén Vidriales, MD PhD, Joan Blade, Juan José Lahuerta, MD PhD, Maria-Victoria Mateos, Jesus F. San Miguel
Journal: Blood
Blood (2014) 124 (21): 3390.
https://doi.org/10.1182/blood.V124.21.3390.3390
Published: 2014
Journal Articles

Novel Ex Vivo Assay Measures Drug-Induced Depletion of Hematopoietic Progenitors As an Estimate of Hematotoxicity

Daniel Primo, PhD, Joan Ballesteros, PhD, Antonio Jimenez, MD, Ataulfo Gonzalez, MD, Miguel Hernandez, MD, Raul Cordoba, MD, Yolanda González, MD, Hernan Jose Moreno, MD, Alicia Bailen, MD, Jesus Martin, MD, Anabelle Chinea, MD, Asuncion Etxeveste, MD, Jose Mariano Hernandez, MD, Albert Oriol, MD, Jaime Perez de Oteiza, MD, Luis Palomera, Cristina Encinas, MD, Felipe Prosper, MD, Rebeca Iglesias, MD, Laura Rosiñol, MD PhD, Alicia Robles, Julian Gorrochategui, Veronica Garcia, Pilar Hernandez, PhD, Enrique Ocio, MD, Joaquin Martinez, MD
Journal: Blood
Blood (2014) 124 (21): 5785.
https://doi.org/10.1182/blood.V124.21.5785.5785
Published: 2014
Journal Articles

Phenotypic and Genomic Analysis Of Multiple Myeloma (MM) Minimal Residual Disease (MRD) Clonal Plasma Cells (PCs)

Bruno Paiva, Luis A Corchete, Norma Gutierrez, PhD, MD, María-Belén Vidriales, MD, PhD, Irene Aires-Mejia, Maria Luz Sanchez, Paloma Barcena, Teresa Paíno, María Asunción Echeveste, Miguel Hernandez, MD, Ramon Garcia-Sanz, Enrique M. Ocio, Albert Oriol, MD, Mercedes Gironella, MD, Luis Palomera, MD, Felipe de Arriba, Yolanda Gonzalez, Juan-Jose Lahuerta, MD, Joan Blade, MD, Alberto Orfao, Maria-Victoria Mateos, MD, Ph.D, Jesus F San Miguel, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 402.
https://doi.org/10.1182/blood.V122.21.402.402
Published: 2013
Journal Articles

A Randomized Phase II Study Comparing Consolidation With a Single Dose Of 90 y Ibritumomab Tiuxetan (Zevalin®) (Z) Vs. Maintenance With Rituximab (R) For Two Years In Patients With Newly Diagnosed Follicular Lymphoma (FL) Responding To R-CHOP. Preliminary Results At 36 Months From Randomization

Armando Lopez-Guillermo, MD, PhD, Miguel A. Canales, MD, PhD, Ivan Dlouhy, Javier Briones, MD, Dolores Caballero, MD, PhD, Juan Manuel Sancho, Sr., MD, Santiago Mercadal Vilchez, MD, Jose María Moraleda, MD, María José Terol, MD, PhD, Antonio Salar, MD, Luis Palomera, MD, Santiago Gardella, MD, Isidro Jarque, MD, Secundino Ferrer, Joan Bargay, MD, Andres Lopez, Carlos Panizo, Anna Muntanola, MD, Carlos Montalban, Eulogio Conde, MD, PhD, Miguel Hernandez, MD, Alfons Soler, Julian Marin, MD, Jose García Marco, Guillermo Deben, José Francisco Tomas, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 369.
https://doi.org/10.1182/blood.V122.21.369.369
Published: 2013
Journal Articles

Autologous Stem Cell Transplantation with Yttriumm-90-Ibritumomab Tiuxetan (Zevalin) Plus BEAM Conditioning in Patients with Refractory Non-Hodgkin Diffuse Large B-Cell Lymphoma: Results of a Prospective, Multicenter, Phase II Clinical Trial

Javier Briones, MD, Silvana Novelli, MD, Jose Antonio Garcia Marco, MD, Jose Francisco Tomas, MD, Teresa Bernal, MD, Carlos Grande, Miguel Canales, Antonio Torres, MD, José M. Moraleda, MD, Carlos Panizo, Fernanda Palmero, MD, Isidro Jarque, MD, Miguel Hernandez, MD, Eva Gonzalez Barca, MD, Dulce Lopez, Dolores Caballero, MD
Journal: Blood
Blood (2012) 120 (21): 1978.
https://doi.org/10.1182/blood.V120.21.1978.1978
Published: 2012